Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance of Anti-Cancer Therapy in the Elderly

NCT05251922 is registered in ClinicalTrials.gov with The Leeds Teaching Hospitals NHS Trust as lead sponsor.

NCT NCT05251922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05251922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance of Anti-Cancer Therapy in the Elderly
Lead sponsor
The Leeds Teaching Hospitals NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2020
Completion date
June 1, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic toxicity, frailty